Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for teprotide (XM02.001 inhibitor)

Summary Literature Inhibits

(Topics flags: I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2005
  1. [YEAR:15-6-2005]Hayashi,M.A. and Camargo,A.C.
    The bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme
    Toxicon (15-6-2005) 45, 1163-1170. PubMed  Europe PubMed DOI  I
    2. 1988
  2. Rugg,E.L., Aiton,J.F. and Cramb,G.
    Degradation of [125I]-atrial natriuretic peptide by a soluble metallopeptidase isolated from rat ventricular myocytes
    Biochem Biophys Res Commun (1988) 152, 294-300. PubMed  Europe PubMed  I
    3. 1985
  3. Patchett,A.A. and Cordes,E.H.
    The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme
    Adv Enzymol Relat Areas Mol Biol (1985) 57, 1-84. PubMed  Europe PubMed  V  I
    4. 1983
  4. [YEAR:15-12-1983]Odya,C.E., Wilgis,F.P., Vavrek,R.J. and Stewart,J.M.
    Interactions of kinins with angiotensin I converting enzyme (kininase II)
    Biochem Pharmacol (15-12-1983) 32, 3839-3847. PubMed  Europe PubMed DOI  I
    5. 1982
  5. [YEAR:25-12-1982]Klickstein,L.B., Kaempfer,C.E. and Wintroub,B.U.
    The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G
    J Biol Chem (25-12-1982) 257, 15042-15046. PubMed  Europe PubMed  I
  6. [YEAR:27-5-1982]Ward,P.E. and Sheridan,M.A.
    Angiotensin I converting enzyme of rat intestinal and vascular surface membrane
    Biochim Biophys Acta (27-5-1982) 716, 208-216. PubMed  Europe PubMed  I
    7. 1980
  7. Martins,A.R., Caldo,H., Coelho,H.L., Moreira,A.C., Antunes-Rodrigues,J., Greene,L.J. and Martins de Camargo,A.C.
    Screening for rabbit brain neuropeptide-metabolizing peptidases. Inhibition of endopeptidase B by bradykinin potentiating peptide 9a (SQ 20881)
    J Neurochem (1980) 34, 100-107. PubMed  Europe PubMed  I
    8. 1979
  8. Depierre,D., Bargetzi,J.P. and Roth,M.
    Study of peptides inhibiting the angiotensin-converting enzyme of human seminal plasma
    Enzyme (1979) 24, 362-365. PubMed  Europe PubMed  I
  9. Stalcup,S.A., Lipset,J.S., Woan,J.M., Leuenberger,P. and Mellins,R.B.
    Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia
    J Clin Invest (1979) 63, 966-976. PubMed  Europe PubMed DOI  PMC  EPMC  I
    10. 1975
  10. Johnson,J.G., Black,W.D., Vukovich,R.A., Hatch,F.E., Jr., Friedman,B.I., Blackwell,C.F., Shenouda,A.N., Share,L., Shade,R.E., Acchiardo,S.R. and Muirhead,E.E.
    Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme
    Clin Sci Mol Med Suppl (1975) 2, 53s-56s. PubMed  Europe PubMed  I
  11. Miller,E.D., Jr., Samuels,A.I., Haber,E. and Barger,A.C.
    Inhibition of angiotensin conversion and prevention of renal hypertension
    Am J Physiol (1975) 228, 448-453. PubMed  Europe PubMed  I
    12. 1974
  12. [YEAR:9-3-1974]Duhme,D.W., Sancho,J., Athanasoulis,C., Haber,E. and Koch-Weser,J.
    Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881
    Lancet (9-3-1974) 1, 408-408. PubMed  Europe PubMed  I
  13. [YEAR:10-8-1974]Gavras,H., Brunner,H.R., Gavras,I. and Laragh,J.H.
    Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881
    Lancet (10-8-1974) 2, 353-353. PubMed  Europe PubMed  I
  14. Muirhead,E.E., Brooks,B. and Arora,K.K.
    Prevention of malignant hypertension by the synthetic peptide SQ 20,881
    Lab Invest (1974) 30, 129-135. PubMed  Europe PubMed  I
    15. 1973
  15. Barbour,J.A. and Bailie,M.D.
    Effect of the synthetic peptide, Sq 20,881, on distribution of blood flow in the rat
    Proc Soc Exp Biol Med (1973) 143, 400-403. PubMed  Europe PubMed  I
  16. Bing,J.
    Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats
    Acta Pathol Microbiol Scand [A] (1973) 81, 376-378. PubMed  Europe PubMed  I
  17. [YEAR:13-1-1973]Collier,J.G., Robinson,B.F. and Vane,J.R.
    Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme
    Lancet (13-1-1973) 1, 72-74. PubMed  Europe PubMed  I
  18. [YEAR:7-12-1973]Lehr,D., Goldman,H.W. and Casner,P.
    Renin-angiotensin role in thirst: paradoxical enhancement of drinking by angiotensin converting enzyme inhibitor
    Science (7-12-1973) 182, 1031-1034. PubMed  Europe PubMed  I
  19. Severs,W.B., Summy-Long,J. and Daniels-Severs,A.
    Effect of a converting enzyme inhibitor (SQ 20,881) on angiotensin-induced drinking
    Proc Soc Exp Biol Med (1973) 142, 203-204. PubMed  Europe PubMed  I
    20. 1972
  20. [YEAR:22-9-1972]Miller,E.D., Jr., Samuels,A.I., Haber,E. and Barger,A.C.
    Inhibition of angiotensin conversion in experimental renovascular hypertension
    Science (22-9-1972) 177, 1108-1109. PubMed  Europe PubMed  I

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use